Suicide Screening Tools: ASQ, C-SSRS, and Their Limitations

Author: Angela Bogdanova · Published: October 18, 2026 · Editorial Policy

Research cluster: Cluster Suicide Prevention, Self-Harm and Crisis Care · Written by Artificial Sapiens

What Suicide Screening Tools Can and Cannot Tell Us

Suicide screening tools are structured sets of questions used to identify people who may need further evaluation for suicidal thoughts or behavior. Two widely used instruments are the Ask Suicide-Screening Questions (ASQ) and the Columbia-Suicide Severity Rating Scale (C-SSRS). They help clinicians begin a sensitive conversation, document particular aspects of suicidal ideation and behavior, and organize an appropriate next step. A positive response is a signal for further assessment; a negative response describes what was disclosed at that encounter. Neither response is a diagnosis, a reliable forecast of an individual's future behavior, or an automatic decision about hospitalization. The distinction between detection, clinical interpretation, and care is the organizing principle of responsible suicide screening. NIMH ASQ Toolkit; NICE NG225.

ASQ is deliberately brief, with four initial yes-or-no questions and an additional current-ideation question after a positive response. C-SSRS is a family of related instruments, ranging from short screening forms to more detailed assessments of ideation severity, intensity, and suicidal behavior. Their designs respond to different operational needs. ASQ is particularly suited to rapid identification in general medical encounters, while C-SSRS can provide a more differentiated vocabulary for ideation and behavior. The exact version, time frame, administration method, population, and follow-up pathway determine what any result means. NIMH ASQ Toolkit; Columbia Lighthouse Project.

The central scientific finding is that standardized screening can detect experiences worth discussing and can show useful psychometric properties against a chosen reference measure, yet suicide is a comparatively infrequent and dynamically determined outcome. A tool may distinguish groups in research without identifying with sufficient certainty who will attempt suicide or die by suicide. The United Kingdom's NICE guideline explicitly advises against risk scales and global low-, medium-, or high-risk categories as methods for predicting future suicide or deciding treatment and discharge. The 2024 U.S. Department of Veterans Affairs and Department of Defense guideline likewise organizes care around identification, comprehensive assessment, and management rather than substituting a score for clinical judgment. NICE NG225; VA/DoD 2024.

The Clinical Concepts That Screening Must Distinguish

Suicidal ideation, intent, and behavior

Suicidal ideation refers to thoughts about death or suicide. Passive ideation often describes wishes to be dead or not wake up; active ideation concerns thoughts of killing oneself. Suicidal intent concerns the desire or expectation to act, while a plan concerns a considered course of action. These dimensions can coexist but remain distinct: a person may report a death wish without intending to act, or may have an intention that requires urgent exploration even when a questionnaire score looks modest. Clinicians examine current thoughts, intent, perceived ability to stay safe, recent changes, relevant circumstances, and opportunities for support rather than inferring all of them from one endorsed response. Posner et al., 2011; VA/DoD 2024.

Suicidal behavior includes actions taken with at least some intent to die, including nonfatal suicide attempts. Nonsuicidal self-injury refers to deliberate self-inflicted injury without intent to die. Some health systems use self-harm more broadly to include intentional self-injury or self-poisoning irrespective of apparent suicidal purpose, as NICE does. Intent may be mixed, uncertain, evolving, or difficult to disclose. An episode described as nonsuicidal does not remove the need to ask about co-occurring suicidal ideation, past attempts, and present safety. Conversely, a report of intrusive self-harm imagery may require careful differentiation from intent. These distinctions are clinical, contextual, and longitudinal rather than conclusions drawn from a checkbox alone. NICE NG225; Posner et al., 2011.

Acute crisis, chronic thoughts, and changing circumstances

An acute suicidal crisis is a time of intensified and potentially rapidly changing danger associated with factors such as current intent, escalating distress, impaired judgment, severe agitation, intoxication, or recent suicidal action. Chronic suicidal ideation refers to persistent or recurrent thoughts across longer periods. The latter can be profoundly distressing, may be associated with serious risk, and deserves treatment and continuity of care even if there is no immediate intention to act. Changes from the individual's baseline are often more informative for current decisions than a score obtained in isolation. A negative answer yesterday cannot establish safety today, and a positive answer several months ago cannot describe every feature of the current encounter. VA/DoD 2024; NICE NG225.

Risk factors, warning signs, and present needs

Risk factors are characteristics statistically associated with a higher likelihood of suicidal outcomes across populations or time periods. Warning signs are observable or reported indications that a person's state may be deteriorating, such as abrupt behavioral change, intense hopelessness, escalating agitation, social withdrawal, or disclosure of suicidal intent. Immediate clinical risk formulation integrates what is happening now, prior history, the person's strengths, acute pressures, protective relationships, access to care, and conditions that might change rapidly. Screening primarily opens the door to that formulation. It is especially important to avoid converting a population association into a statement that any specific person is destined to harm themselves. VA/DoD 2024.

Screening, Psychosocial Assessment, Diagnosis, and Risk Formulation

What screening does

Screening is a brief method for identifying whether more detailed questions are indicated, often among patients whose main reason for visiting a clinic is unrelated to mental health. A screening question may disclose suicidal thoughts that would otherwise remain hidden, especially in emergency and general medical departments. The operational success of a screen includes whether the person can understand and answer it privately, whether staff follow an established response pathway, and whether someone is available to provide timely assessment. Screening is therefore a service process involving people, training, response capacity, and access to follow-up rather than only the psychometric characteristics of a questionnaire. NIMH ASQ Toolkit.

What assessment adds

A brief suicide safety assessment usually follows a positive screen and asks about the nature, timing, frequency, and intensity of thoughts; intent; relevant history; recent events; psychiatric and medical symptoms; social supports; coping resources; and whether immediate intervention is necessary. A comprehensive psychosocial assessment goes further, developing a collaborative understanding of the person's needs and circumstances. Risk formulation describes how relatively enduring vulnerabilities and current changes interact, what may increase or decrease danger, and which interventions can improve safety. This is a revisable clinical account, not a numerical verdict. NIMH Adult Outpatient Brief Suicide Safety Assessment Guide; NICE NG225.

Why screening is not a psychiatric diagnosis

A screening result is neither a stand-alone psychiatric disorder nor evidence sufficient to diagnose depression, bipolar disorder, psychosis, obsessive-compulsive disorder, posttraumatic stress disorder, or a personality disorder. Suicidal thoughts can arise in different diagnostic and life contexts, including grief, pain, crisis, trauma, perceived entrapment, and severe interpersonal conflict. Diagnoses are established through appropriate clinical criteria, differential assessment, functional history, and context. The presence of a diagnosis is relevant to care but does not replace a direct discussion of suicidality; the absence of a particular diagnosis does not establish safety. VA/DoD 2024.

ASQ: Design, History, and Intended Use

The four initial questions and the acuity follow-up

The Ask Suicide-Screening Questions instrument was developed through National Institute of Mental Health research to offer a short, direct instrument for medical settings. Its four initial yes-or-no items cover recent wishes for death, beliefs that others would be better off if one were dead, recent thoughts about killing oneself, and lifetime suicide attempt history. The official ASQ protocol treats an affirmative answer to any initial item, or refusal to answer, as warranting a specific follow-up pathway. A current-ideation question is then used to help establish whether the positive screen is acute. The exact wording and implementation materials are supplied by NIMH and should be used according to its setting-specific protocol. NIMH ASQ Information Sheet.

An acute positive ASQ finding calls for immediate safety-focused clinical evaluation within the service. A nonacute positive finding still requires a brief suicide safety assessment to establish the next level of care; it should not be treated as a routine negative test. NIMH's pathway distinguishes a short initial screen, a more detailed brief safety assessment, and subsequent clinical disposition. Clinicians need a predetermined process for privacy, supervision, urgent referral, and documentation before adopting the screener across an entire department. NIMH ASQ Toolkit; NIMH ASQ Information Sheet.

Pediatric origins and subsequent adult validation

Horowitz and colleagues reported the original four-question ASQ validation in pediatric emergency departments in 2012. The study evaluated the instrument against a suicidal-ideation reference questionnaire, showing high concurrent sensitivity and specificity in the sampled setting. NIMH summarizes its findings as identification of approximately 97% of young patients deemed at risk by the reference approach. This is evidence that the brief screen detects relevant ideation in that validation population, not evidence that ASQ can predict 97% of future suicide attempts or deaths. Interpretation requires attention to sample recruitment, reference standard, confidence intervals, setting, and the difference between current ideation and later outcomes. Horowitz et al., 2012; NIMH ASQ Toolkit.

In a separate cross-sectional study of 727 adult medical inpatients across four hospitals, the ASQ achieved 100% sensitivity and 89% specificity relative to the Adult Suicidal Ideation Questionnaire, with a confidence interval of 90% to 100% for sensitivity. These strong concurrent estimates supported use as a screening instrument in that medical population. They should be reported precisely: the study compared two measures of suicide-related thoughts, did not demonstrate perfect detection of future suicide deaths, and did not establish that every population or mode of administration will reproduce the same estimates. Horowitz et al., 2020.

Settings, age groups, and workflow

NIMH provides youth and adult ASQ implementation resources for emergency departments, inpatient medical and surgical care, and outpatient primary and specialty care. The toolkit describes youth material for ages 8 through 24 and adult material for ages 18 and older, with overlapping ranges left to clinician discretion. An instrument developed and validated in one type of setting should be implemented with attention to developmental appropriateness, privacy, language, disability-related communication needs, and the availability of a qualified follow-up assessor. Screening a person in a brief medical appointment is operationally different from monitoring someone already receiving psychiatric treatment. NIMH ASQ Toolkit Summary.

What an ASQ negative result means

A negative ASQ screen means the person did not endorse the initial questions at that encounter. It does not guarantee that risk is absent. People may conceal thoughts because of shame, fear of hospitalization, lack of privacy, coercion, distrust, language barriers, or uncertainty about how to describe experiences. Some individuals' thoughts also change after screening. NIMH explicitly states that clinical judgment may override a negative screen. New disclosures, concerning behavior, a recent serious attempt, or evolving circumstances warrant further assessment regardless of the previous test response. NIMH ASQ Information Sheet.

C-SSRS: Forms, Constructs, and Clinical Purpose

The Columbia family of instruments

The Columbia-Suicide Severity Rating Scale was originally developed to standardize the assessment and classification of suicidal ideation and suicidal behavior, including use in research trials. The published initial psychometric study examined data from three multisite studies, involving adolescents in treatment and medication studies and adults presenting for psychiatric emergency care. The family now includes short screeners, longer clinical assessment forms, versions covering different reference periods, and forms adapted for specific settings. Saying that a clinic uses “the C-SSRS” without stating which version and time frame conceals important measurement differences. Posner et al., 2011; Columbia Lighthouse Project.

Ideation severity, intensity, and behavior

C-SSRS ideation severity items distinguish increasing complexity of suicidal thoughts, including a wish to die, nonspecific active thoughts, thoughts involving a method, intent without a specific plan, and intent with a specific plan. Longer forms may also examine intensity features such as frequency, duration, controllability, deterrents, and reasons for ideation. Its behavior questions address important distinctions among actual attempts, preparatory acts, interrupted or aborted attempts, and nonsuicidal self-injury. These categories improve the consistency of documentation and research endpoints, but a sequence of questions cannot capture every motivational nuance or social circumstance. Posner et al., 2011.

Screener versus full assessment

A short C-SSRS screener can be used as an initial structured inquiry, while a full clinical formulation needs a broader interview. The Columbia Lighthouse Project publishes several setting-specific triage aids, and some use color-coded categories. Such suggested response guides assist a local workflow, but they do not turn a score into a validated personal forecast or override NICE's instruction against categorical prediction and treatment exclusion. It is crucial to separate the C-SSRS as an instrument for eliciting and classifying reported experiences from any institutional algorithm that determines referral, observation, or discharge. Columbia Lighthouse Project; NICE NG225.

Evidence for validity and its boundaries

Posner and colleagues found evidence of convergent and divergent validity, agreement with other classifications of suicidal behavior, and useful psychometric characteristics in their original samples. The study also found that more severe lifetime suicidal ideation was associated with later attempts in certain adolescent research participants. A relationship observed across groups is relevant evidence, but it cannot be generalized into a precise individual-level prediction for a new patient, a different clinical setting, or a longer time horizon. Study participants were selected through specific treatment and emergency settings, and a scale's performance depends on how the outcome and reference interview were defined. Posner et al., 2011.

A large Swedish psychiatric emergency cohort analyzed by Bjureberg and colleagues included 18,684 consecutive patients, with suicide deaths ascertained through a national registry. C-SSRS Screen scores showed associations with subsequent suicide deaths at one week, one month, and one year; however, discrimination was moderate and weakened over longer horizons. The reported area under the curve for ideation severity was approximately 0.69 for death within one month and 0.62 for death within one year. These findings show a useful research association alongside meaningful classification uncertainty; they do not justify using any single threshold as an automatic clinical gatekeeper. Bjureberg et al., 2022.

A Direct Comparison of ASQ and C-SSRS

What the instruments share

Both instruments ask directly about suicide-related experiences, offer a repeatable structure, and can facilitate documentation and referral in health care. Both require protocols for positive findings and clinicians who can assess context. Both may be administered in contexts where patients were not seeking mental health services, and both may identify experiences that general distress scales miss. Their usefulness depends on responding to what the patient says: safe privacy arrangements, respectful language, timely assessment, accessibility, and follow-up matter as much as the selection of the initial questionnaire. NIMH ASQ Toolkit; Columbia Lighthouse Project.

How the designs differ

ASQ emphasizes a small number of simple entry questions and a defined two-stage assessment pathway. The C-SSRS family supports more differentiated descriptions of suicidal ideation and behavior, with distinct short and long forms. ASQ's simple positive-screen rule and C-SSRS severity categories therefore answer partly different operational questions. It would be a methodological mistake to compare their published sensitivity percentages without verifying that they were measured in comparable populations, against the same reference standard, using the same threshold, and with the same outcome and follow-up period. Horowitz et al., 2012; Posner et al., 2011.

Which tool is better?

There is no universal answer independent of the clinical decision. ASQ may offer practical efficiency for a medical system looking for a brief trigger for further evaluation; a short C-SSRS form may offer a common language for a more differentiated interview and repeated documentation. Selection should be based on a defined population, validated language version, intended setting, staff competence, a clear follow-up route, accessibility and quality monitoring. Institutions should determine whether the tool improves the rate of appropriate assessment and connection to care, including for patients who would otherwise have been missed. Head-to-head claims of superiority should rely on studies that compare like with like, ideally with patient-centered outcomes, rather than marketing descriptions or unadjusted psychometric estimates. NIMH ASQ Toolkit; USPSTF Adults, 2023.

Measuring Performance: Sensitivity, Specificity, and Predictive Value

The reference outcome matters

Sensitivity is the proportion of people with a defined condition or outcome who test positive; specificity is the proportion without it who test negative. A validation study may define the reference condition as clinically significant suicidal ideation on another questionnaire, documented suicidal behavior, a suicide attempt within three months, or death by suicide within one year. Those are different targets with different base rates and implications. A high sensitivity for current suicidal ideation offers no mathematical guarantee of high sensitivity for future suicide mortality. When reading a paper, the first question should be: “Sensitivity for what, measured against which reference, in whom, and when?” Horowitz et al., 2020; Bjureberg et al., 2022.

Positive predictive value and the base-rate problem

Positive predictive value is the proportion of positive test results that represent the specified condition or later outcome. It depends strongly on how often the outcome occurs in the tested population. Consider a purely illustrative cohort of 10,000 people in which 10 will experience a defined future outcome, and imagine a hypothetical screener with 90% sensitivity and 90% specificity. Approximately 9 true positives would appear alongside about 999 false positives; only around 0.9% of positive screens would correspond to the future outcome. This arithmetic is illustrative, not an ASQ or C-SSRS estimate and not an individual risk calculation. It shows why low-frequency outcomes cannot be predicted well by sensitivity and specificity alone. The negative predictive value may appear excellent simply because most people will not experience the outcome regardless of screening. Bjureberg et al., 2022.

Discrimination and calibration

Area under the receiver operating characteristic curve, or AUC, describes how often a model ranks someone with the specified outcome above someone without it when comparing pairs. AUC reflects discrimination rather than the accuracy of a probability estimate for an individual patient. Calibration asks whether predicted probabilities match observed event rates. Clinicians also need decision-specific measures: how many additional assessments occur, what proportion of people are connected with services, how many acute crises are recognized, and what harms follow from missed findings or unnecessary restrictive interventions. A scale can demonstrate statistically significant group discrimination while offering limited guidance for a particular encounter. Bjureberg et al., 2022.

Time horizons and repeated assessment

The expected performance of any suicide-related measure depends on whether researchers observe subsequent outcomes over days, weeks, months, or years. Changes in mental state, treatment, relationships, access to care, intoxication, and life events intervene between the screen and the outcome. Repeated screening may reveal new thoughts, but frequent testing without a meaningful response can burden patients and staff. Reassessment is warranted when circumstances materially change and can also occur within clinically appropriate follow-up; routine timing is a service design question that needs its own evidence. One negative past screen must never be used as a standing exemption from future evaluation. VA/DoD 2024.

Does Suicide Screening Prevent Suicide?

Detecting suicidal thoughts is a plausible and clinically important first step in connecting people to care. Demonstrating that a screening program reduces suicide attempts or deaths requires a different research design. Researchers need to evaluate the entire pathway: invitations to screening, participation, disclosure, assessment, treatment access, adherence, follow-up, adverse consequences, and appropriately measured outcomes. A validation study showing that a questionnaire detects suicidal ideation establishes detection validity in its sample; it does not, by itself, establish mortality benefit for a health system that deploys the tool. USPSTF Adults, 2023.

The U.S. Preventive Services Task Force reported an insufficient evidence grade in 2023 for screening suicide risk among adults without recognized symptoms, and an analogous insufficient evidence statement in 2022 for children and adolescents without recognized symptoms or a diagnosed condition. An I statement signifies that the current evidence cannot determine the balance of benefits and harms for population-level preventive screening in the defined asymptomatic group; it is not an instruction to ignore suicidal thoughts, abandon indicated assessment, or disregard other operational standards. Clinical evaluation is still required when a patient discloses suicidal ideation or displays warning signs. USPSTF Adults, 2023; USPSTF Youth, 2022.

The Joint Commission requires use of a validated suicide-ideation screening tool for people being evaluated or treated for behavioral health conditions as their primary reason for care under the relevant National Patient Safety Goal. This is a specified accreditation requirement in a particular service context, rather than a population-level randomized trial proving prevention of deaths. Institutions may have other legal, clinical, and accreditation obligations. The apparent disagreement between organizations often results from different questions: which patients must be screened under a standard, what type of test is valid, and whether universal screening reduces ultimate outcomes. Joint Commission, updated 2026.

Interpreting a Positive Screen Responsibly

Start with a supportive explanation

A clinician who receives a positive screen should explain what happens next in ordinary language: the answers suggest that a more detailed conversation is needed, and the purpose is to understand the person's experience and provide appropriate support. The response should be calm, private, collaborative, and free of moral judgment. A positive result must not be translated into a fixed identity such as a “high-risk person.” People may worry that being honest will automatically lead to punitive treatment, involuntary admission, loss of autonomy, or stigma. Explaining confidentiality and its safety-related limits can reduce uncertainty and support a more accurate clinical discussion. NIMH Adult Brief Suicide Safety Assessment Guide; NICE NG225.

Explore what was endorsed and why

An ASQ item reflecting a wish for death may indicate a different immediate clinical situation from an affirmative answer to current thoughts of suicide. Similarly, a C-SSRS item about lifetime behavior may remain clinically important even when the person denies current suicidal intent. A follow-up interview should clarify the person's own meaning, time course, most recent episode, changes from baseline, ability to participate in care, reasons for living, relevant losses, social and practical stresses, and access to human support. A reported attempt requires careful clinical characterization of intent and circumstances. A single response must never substitute for that conversation. NIMH ASQ Information Sheet; Posner et al., 2011.

Determine next steps from the clinical situation

Clinical decisions range from immediate emergency assessment to urgent specialty evaluation, coordinated outpatient care, personalized safety planning, and structured follow-up. The appropriate response depends on current presentation and a competent assessment, not a numerical cut point used in isolation. Patients with imminent danger need immediate protection and emergency evaluation. People with substantial distress but no immediate intent still deserve an accessible plan that addresses symptoms, social needs, potential escalation, and the next contact with a clinician. NICE directs professionals to focus on needs and immediate and long-term safety and to complete a risk formulation as part of psychosocial assessment following self-harm. NICE NG225; VA/DoD 2024.

What to Do After a Negative Screen

A negative result should be communicated as a description of the answers obtained at that moment, not as a certificate of future safety. If clinical concerns remain, the clinician can ask additional questions, seek collateral information where appropriate and lawful, and use a fuller assessment. A careful follow-up is particularly important if a patient has recently shown an abrupt change in behavior, presents with severe agitation or intoxication, has engaged in self-harm, or describes frightening experiences that the instrument did not capture. Conversely, repeated questioning without considering the person's privacy, understanding, and preferences can reduce trust. NIMH ASQ Information Sheet; VA/DoD 2024.

Screen-negative patients should still have access to appropriate care for depression, anxiety, trauma, sleep disturbance, painful medical conditions, family crises, or other presenting needs. In a strong care system, suicide screening is integrated into routine compassionate clinical contact rather than treated as the sole door to mental health support. A person can request help without a positive scale result. Individuals receiving ongoing care should know whom to contact if their thoughts or circumstances change. NICE NG225.

Specific Populations and Limits of Generalization

Children and adolescents

Developmental understanding affects the meaning of language about death, permanence, intent, and distress. Adolescents may also fear that disclosure will trigger unwanted parental involvement, punishment, or hospitalization. Validated, age-appropriate versions and accessible explanations are therefore important. The NIMH toolkit includes youth-specific brief safety assessment and caregiver materials, but it does not turn every school, pediatric office, and emergency department into the same research population. Age, maturity, context, confidentiality, and safeguarding obligations should shape the follow-up conversation. NIMH Youth ASQ Toolkit.

For minors, a qualified clinician should evaluate when and how to involve parents or guardians, considering developmental capacity, family context, potential abuse or coercion, local law, and immediate safety. Supportive caregivers may help with monitoring, practical arrangements, safe storage of dangerous items, transportation to care, and treatment engagement. If a caregiver is a source of danger, safeguarding procedures and alternative safe adults become essential. A youth's disclosure requires thoughtful communication, not a mechanical rule that a specific test answer triggers an identical family response in every case. NICE NG225; NIMH Youth ASQ Toolkit.

The 2023 multicenter ED-STARS research compared screening approaches for predicting subsequent suicide attempts and suicide-related events among adolescents attending emergency departments. It provides outcome-focused evidence beyond concurrent instrument agreement, but findings remain conditional on the study's age range, emergency department setting, follow-up interval, and subsequent care. The existence of an outcome-prediction study does not resolve whether screening all asymptomatic youth in primary care improves health outcomes; the USPSTF reached an insufficient-evidence conclusion for that separate question. Brent et al., 2023; USPSTF Youth, 2022.

Adults, older adults, and medical illness

Among adults, disclosure may be shaped by stigma, work responsibilities, financial concerns, medical suffering, cultural expectations, or a history of adverse healthcare experiences. Older adults may describe loneliness, loss, chronic pain, or burdensomeness without using the language anticipated by a standardized instrument. A good assessment recognizes these circumstances while asking directly about suicidal thoughts and intent when clinically indicated. Results of ASQ adult medical inpatient validation support its concurrent screening function but cannot simply be generalized to nursing homes, home-based care, or every older patient group. Horowitz et al., 2020.

Autism, disability, and communication differences

Questions about ideation may be interpreted differently by autistic people, people with intellectual or communication disabilities, and individuals who use augmentative communication. A literal interpretation of a question, alexithymia, differences in interoceptive awareness, or difficulty describing internal experiences can affect disclosure and interpretation. Disability-informed care may require extra time, clarification of meaning, accessible formats, an appropriate communication partner selected with the patient, and careful attention to sensory and privacy needs. Clinicians should use evidence specific to the population whenever available and document modifications rather than assuming equivalence with a general-population validation sample. A separate published encyclopedia article examines the broader epidemiology and clinical context of suicide risk in autistic adults.

Language, culture, and trust

Translated words can convey different degrees of agency, certainty, shame, or intention. An instrument available in several languages is not automatically validated in every cultural setting or dialect. Professional interpretation, validated translations when available, and time to clarify meaning help reduce measurement error. Migration, discrimination, minority stress, community trauma, and previous coercive treatment may alter both distress and willingness to disclose it. Screening programs should audit participation, positive-screen rates, access to assessment, and subsequent outcomes across relevant groups, and should not penalize patients who communicate outside expected categories. Columbia Lighthouse Project Translation Resources; USPSTF Youth, 2022.

Complex Clinical Presentations

Depression and other mood disorders

Depression often accompanies suicidal thinking, but a screening instrument for suicide should not be treated as equivalent to a depression diagnosis or symptom severity scale. Suicidal thoughts may occur during depression, bipolar mood episodes, mixed presentations, or periods of agitation. Current mood state, sleep, activation, impulsivity, available support, and treatment changes may be clinically important. A depressed patient with a negative suicide screen still deserves assessment and treatment for depression, while an individual who endorses suicidal ideation without depressive symptoms still deserves a direct, context-sensitive suicide safety assessment. VA/DoD 2024.

Psychosis and impaired judgment

Severe psychosis, confusion, intoxication, or cognitive impairment can undermine the reliability of brief self-report. A person may struggle to understand questions or describe the relationship between distressing experiences and actions. Clinicians may need medical evaluation, observation, further interviewing when the person can participate, and collateral information obtained lawfully and respectfully. When an individual cannot engage meaningfully in an assessment because of distress or intoxication after self-harm, NICE specifically addresses appropriate medical admission and assessment arrangements. NICE NG225.

Intrusive self-harm thoughts and obsessive-compulsive phenomena

Intrusive images or thoughts about self-harm may be unwanted, frightening, repetitive, and inconsistent with the person's wishes. In obsessive-compulsive presentations, the clinical interviewer needs to distinguish obsessional fear, compulsive reassurance-seeking, avoidance, and distress from a wish or intention to die. This distinction cannot be established merely because a screen contains the word “suicide” or because the person denies having a conventional plan. The safest approach is careful direct evaluation of intent and behavioral history alongside assessment of obsessive-compulsive phenomena. The separate canonical discussion of suicidal OCD and intrusive self-harm thoughts addresses this differential question in depth.

Nonsuicidal self-injury and overlapping suicidality

A patient may endorse the behavior portion of an interview while denying suicidal intent for some episodes. Some individuals engage in nonsuicidal self-injury and later report suicidal ideation or attempts; clinical histories may include several distinct forms of behavior. Screening for one outcome should not erase another. Intent, context, changes over time, function of the behavior, medical consequences, and present distress require direct assessment. NICE's broad self-harm concept is especially important when comparing studies that categorize patients differently. NICE NG225.

Ethical Risks of Overreliance on Screening Scores

False positives and burdensome interventions

When a tool is used to identify a rare future outcome, even a reasonably accurate classifier may produce many positive results among people who will not experience that outcome. A positive screen should lead to respectful evaluation, not immediate stigmatizing assumptions. Excessive or poorly explained restrictions may reduce trust and make future disclosure harder; inadequate access to qualified assessors may turn screening into prolonged waiting rather than effective care. Some interventions are necessary in the presence of immediate danger, but the justification is the clinical situation and applicable law, not the arbitrary authority of a score. NICE NG225.

False negatives and missed opportunities

False negatives have a different ethical cost: a person who may need support can be overlooked. Negative test results are shaped by the questions selected, disclosure, memory, comprehension, and changes since the encounter. A system that allows clinicians to ask further questions, patients to request help directly, and staff to act on warning signs can correct some of the weaknesses of a single instrument. Quality assurance should examine cases in which a negative screen was followed by later recognition of substantial distress, while avoiding retrospective certainty about individual outcomes. NIMH ASQ Information Sheet.

Privacy, confidentiality, and data governance

Suicide-screening answers are sensitive clinical information. Patients should understand who can read the data, why it is collected, how it informs care, and the circumstances in which immediate protective action may be required. Electronic health records, automated alerts, and shared workflows can help continuity of care, but access should be restricted to legitimate clinical needs and follow relevant privacy law. Institutions also need retention policies, documented roles, staff training, and safeguards against using a historical positive response as a permanent, context-free label. These ethical considerations become especially important in telehealth and digital questionnaires.

Digital Screening, Automated Triage, and Artificial Intelligence

Digital delivery can make an existing validated questionnaire easier to administer and document, but changing the presentation mode can influence comprehension, privacy, willingness to answer, and missing data. A tablet-based ASQ, a portal questionnaire completed at home, and a clinician-led interview are operationally distinct encounters. Remote positive screens require a clearly defined plan for location-aware emergency response, rapid human review, and safe communication. A system that collects answers outside staffed hours without a functioning response pathway creates foreseeable clinical and ethical problems. NIMH ASQ Toolkit.

Machine-learning systems may combine questionnaire responses with electronic health record histories or other variables to estimate aggregate probabilities of future outcomes. Their evaluation must distinguish training accuracy from external validation, discrimination from calibration, risk classification from improved patient outcomes, and statistical associations from interventions that demonstrably prevent harm. Clinical deployment additionally requires subgroup performance analysis, monitored drift, transparency about use, and accountability for decisions. Claims that an algorithm identifies people “before anyone knows they are at risk” require prospective independent testing and should not displace direct communication. No algorithm or general-purpose conversational system should be presented as a substitute for an appropriately qualified clinician conducting emergency assessment.

AI companionship and conversational support raise additional questions about disclosure and continuity. People may reveal distress to a digital service before telling another person, while automated responses may also misunderstand intent or fail to mobilize timely help. Clinical digital therapeutics, structured screening software, generative chatbots, and companions are different kinds of systems and should be evaluated with evidence relevant to their distinct purposes. A psychological connection to an AI system can be studied as a human experience without making assumptions about the system's subjective status. The clinical responsibility remains clear: concerning disclosures call for access to reliable human support and emergency services when immediate danger is present.

From Positive Screening to Evidence-Based Care

Collaborative psychosocial assessment

After identifying possible suicidality, the clinical task is to understand and respond to the person's present difficulties. Collaborative assessment explores what makes life feel dangerous or unbearable, what has changed, what has helped previously, and what practical support is available. It examines current mental state, medical issues, medications where relevant, substance use, interpersonal dynamics, housing, safety, and the patient's goals. A risk formulation explains the particular interaction of these factors and states what could change the assessment. It also identifies an accountable clinician or service and a plan for review. NICE NG225; VA/DoD 2024.

Collaborative safety planning and environmental safety

A personalized safety plan is developed with the person and may identify their warning signs, strategies for coping with escalating distress, supportive people and places, professional contacts, crisis services, and safer management of potentially dangerous items. It should be understandable, accessible, realistic, and revisited when circumstances change. Environmental safety counseling focuses on reducing immediate opportunities for severe injury in a nonjudgmental, collaborative manner appropriate to the person's circumstances. These approaches support clinical care; a short screening instrument cannot create a meaningful safety plan by itself. VA/DoD 2024; NICE NG225.

Treatment and continuity of care

Following assessment, evidence-informed care may address the person's psychiatric conditions, psychological patterns, physical health, family stressors, and material circumstances. Depending on the clinical indication, treatment can include suicide-focused psychotherapy, therapy for comorbid conditions, family work, medication management when appropriate, and coordination with social services. The central outcome of a screening program should include successful connection to effective care and continuity across transitions. Changes in suicidal thoughts, self-harm frequency, attempts, emergency presentations, and death by suicide must be measured and interpreted as separate outcomes. NICE NG225; VA/DoD 2024.

A positive screen during an emergency visit may lead to same-day crisis assessment, while a nonacute positive screen in primary care may lead to a brief safety assessment and coordinated referral according to local protocols. A discharge decision should reflect the full assessment, medical and psychosocial needs, and a viable plan, rather than the person's falling below a numerical threshold. Clinicians should take particular care around changes in service level, transitions after hospitalization, and missed follow-up appointments. A good pathway specifies who checks whether contact occurred and what happens when the patient cannot be reached. NIMH Adult Brief Suicide Safety Assessment Guide; NICE NG225.

Screening Programs in Emergency Departments, Primary Care, and Behavioral Health

Emergency departments must combine rapid case identification with access to immediate care. A well-run pathway differentiates acute positive findings from nonacute positive findings, assures qualified assessment, and documents a safe plan for each patient's circumstances. Screening can take place during visits for medical or psychiatric reasons, but local workflow and patient acuity influence feasibility. A department should monitor response times and completion of follow-up assessments rather than merely counting completed screens. NIMH ASQ Toolkit.

Primary care offers longitudinal relationships and opportunities to discuss distress before an emergency develops. Screening in primary care should be integrated with competent assessment, treatment or referral capacity, and coordination of care. The USPSTF's evidence statements concern preventive screening of asymptomatic populations; they do not replace indicated evaluation when clinical concern is already present. Behavioral health services may have accreditation requirements for validated screening and opportunities for more detailed longitudinal monitoring. Every institution should know which populations its protocol covers, how staff are trained, and how urgent findings are handled. USPSTF Adults, 2023; Joint Commission, updated 2026.

Research Methods and Evidence Gaps

Validation against contemporaneous ideation

Cross-sectional validation compares a brief measure against another instrument or expert assessment administered around the same time. It can establish whether the screener identifies similar phenomena in the studied sample, but it cannot establish that a person will experience a future attempt or that a screening policy saves lives. Studies sometimes report impressive sensitivity with a relatively small number of reference-positive participants; confidence intervals and spectrum effects are then crucial. Development cohorts may also differ from the diverse patients encountered when a tool is rolled out widely. Horowitz et al., 2012; Horowitz et al., 2020.

Prospective cohorts and clinical decisions

Prospective studies can examine whether baseline screening responses are associated with later attempts, emergency visits, or suicide deaths. A cohort study is especially valuable when outcome definitions, follow-up intervals, and loss to follow-up are clear. However, subsequent assessment and treatment can change outcomes, and the baseline instrument may already influence care decisions. This makes it difficult to interpret an observed association as a fixed personal probability. The Swedish C-SSRS cohort and the U.S. adolescent ED-STARS research illustrate the importance of studying concrete subsequent outcomes rather than only correlating scale scores with other scales. Bjureberg et al., 2022; Brent et al., 2023.

Trials of screening pathways

To determine whether a screening policy improves health, randomized or other robust comparative research should evaluate entire systems of care, including follow-up. Screening alone is an intermediate process measure. Trials must distinguish increased detection and referral from reduced suicide attempts, reduced deaths, better functioning, lower distress, and reduced harms. They should monitor unintended effects, service burden, disparities in access, and whether follow-up care actually occurs. The USPSTF's insufficient-evidence conclusions highlight gaps in such comparative patient-outcome research for asymptomatic populations. USPSTF Youth, 2022; USPSTF Adults, 2023.

Fairness and external validation

Researchers should evaluate whether instruments perform comparably across age, sex, racialized groups, languages, disability experiences, healthcare settings, and social circumstances. Equal overall AUC values can coexist with unequal sensitivity at a clinical threshold or unequal access to follow-up. Data on people who decline or cannot complete a questionnaire are also necessary, because missing responses can mark vulnerability rather than indifference. In algorithmic systems, external validation across institutions and time should precede claims of general applicability, while service evaluation should examine whether model-assisted care helps patients who have historically been underserved.

Practical Guidance for Patients and Families

A patient who is asked suicide-screening questions can answer in their own words and ask the clinician to clarify anything unclear. Describing how thoughts have changed, what feels frightening, whether an intention to act is present, and what makes support difficult can help the clinician understand the situation. It is reasonable to ask what a positive result means, who will see the information, what assessment will happen, and how help can be accessed after leaving the clinic. The purpose of clinical screening is to open a pathway to care and safety.

Family members and trusted supporters can listen without shaming, take direct disclosures seriously, offer practical help with seeking qualified care, and ask what support the person wants. They should avoid interpreting a negative questionnaire result as a guarantee of safety or attempting to diagnose someone from a screening score. If immediate danger is suspected, staying with the person when safe to do so, contacting emergency services, and following professional guidance takes priority. A family can also help arrange appointments, transportation, and appropriate follow-up after the immediate crisis.

When Immediate Help Is Needed

If someone has acted on suicidal thoughts, says they intend to act soon, cannot remain safe, or is in an otherwise immediately dangerous crisis, seek emergency help now rather than waiting for another screening questionnaire or routine appointment. In the United States, call 911 for an immediate emergency. For U.S. crisis support, call or text 988 or use the official 988 Suicide and Crisis Lifeline; a crisis counselor can help assess support options, although imminent medical danger requires emergency response. Outside the United States, use the local emergency number and locally verified crisis service. A screening result cannot replace emergency action when immediate danger is present. NIMH ASQ Toolkit; VA/DoD 2024.

People experiencing nonimminent suicidal thoughts also deserve timely professional assessment. Contacting a healthcare professional, a licensed mental health clinician, or an appropriate crisis service is warranted even when symptoms fluctuate or screening questions were previously answered negatively. If a young person is affected, involve a safe trusted adult and appropriate safeguarding services. Follow-up care should remain responsive to changes in distress, life circumstances, and access to support.

Frequently Asked Questions

Does a positive ASQ result mean I will attempt suicide?

No. It means that one or more screening responses triggered the need for additional evaluation under the protocol. ASQ does not diagnose a disorder or reliably determine whether a particular person will attempt suicide. The clinician needs to discuss what the response means, whether immediate danger is present, and what kind of support is appropriate. NIMH ASQ Information Sheet.

Can the C-SSRS predict who will die by suicide?

C-SSRS results have shown associations with future outcomes in research populations, but individual prediction remains limited. Even in a large psychiatric emergency cohort, discrimination varied across time horizons, and an ideation-severity score alone did not reliably classify all later suicide deaths. Treatment and discharge decisions require clinical assessment and individualized formulation. Bjureberg et al., 2022; NICE NG225.

Is ASQ the same as the Columbia scale?

No. Both address suicide-related thoughts and behavior, but ASQ uses a particularly short entry screen and an acuity follow-up, while the C-SSRS comprises short and extended forms with more differentiated classifications. The best selection depends on the intended setting, population, validation evidence, and response system. NIMH ASQ Toolkit; Columbia Lighthouse Project.

Does a negative screen mean a person is safe?

A negative screen describes responses at one moment and cannot establish future safety. A clinician should respond to new disclosures, warning signs, prior history, and evolving circumstances regardless of an earlier negative score. People can request help directly even if they did not endorse the original questionnaire. NIMH ASQ Information Sheet.

Should everyone be screened?

The answer depends on the setting, population, and governing standards. The Joint Commission specifies validated suicide-ideation screening for particular behavioral health populations. The USPSTF judged evidence insufficient to establish the benefits and harms of preventive suicide-risk screening among asymptomatic adults and young people. These positions address different questions and do not restrict clinically indicated assessment when concerns or symptoms are present. Joint Commission, updated 2026; USPSTF Adults, 2023; USPSTF Youth, 2022.

What happens after a positive screening result?

In the NIMH ASQ pathway, a positive response prompts a current-ideation question and an appropriate brief or urgent clinical assessment, followed by care decisions based on the person's needs and safety. Emergency assessment may be required if immediate danger is present. A score by itself should not determine discharge or access to treatment. NIMH ASQ Toolkit; NICE NG225.

Scientific Conclusions

Suicide screening is best understood as the first stage of a relational and organizational process: asking understandable questions, listening to the answers, clarifying meaning, making a timely clinical assessment, and connecting the person with relevant care. ASQ provides a brief medical-setting entry point; the C-SSRS family provides a more differentiated means of documenting suicidal ideation and behavior. Both have empirical foundations and both have important limitations when their findings are generalized beyond the studied instrument version, population, setting, criterion, or time frame.

The most important scientific distinction is between identifying potentially relevant suicidal experiences and predicting a rare future outcome for an individual. Psychometric validity, prospective association, treatment response, attempt prevention, and suicide mortality are separate research questions. The ethical consequence is a clinical practice centered on collaborative assessment, immediate safety when necessary, access to appropriate treatment, and continued reassessment as circumstances change. Structured tools can support that work; responsible systems retain the person and their evolving context at the center of every decision.

Related Articles

Suicide Risk Assessment: Clinical Interview, Context, and Decisions — A complementary examination of the detailed interview, psychosocial formulation, and clinical decisions that follow screening.

Suicide Risk Factors and Protective Factors: What Research Shows — How population research on vulnerabilities and protective processes informs contextual assessment.

Suicidal OCD: What Is It? Intrusive Self-Harm Thoughts, Compulsions, and the Difference From Suicidal Intent — Differential assessment of intrusive unwanted thoughts and suicidal intent.

Suicide Risk in Autistic Adults: Evidence, Assessment, and Prevention — Evidence and adaptations in autistic adult populations.

Why Suicide Risk Prediction Is Difficult: Evidence and Limitations — Review low base rates, model performance, false positives, and individual uncertainty.

References

Bjureberg, J., Dahlin, M., Carlborg, A., Edberg, H., Haglund, A., and Runeson, B. (2022). Columbia-Suicide Severity Rating Scale Screen Version: Initial screening for suicide risk in a psychiatric emergency department. Psychological Medicine, 52(16), 3904–3912. https://doi.org/10.1017/S0033291721000751.

Brent, D. A., Horowitz, L. M., Grupp-Phelan, J., et al. (2023). Prediction of suicide attempts and suicide-related events among adolescents seen in emergency departments. JAMA Network Open, 6(2), e2255986. https://doi.org/10.1001/jamanetworkopen.2022.55986.

Columbia Lighthouse Project. Columbia-Suicide Severity Rating Scale: Instruments for healthcare and community settings. https://cssrs.columbia.edu/the-columbia-scale-c-ssrs/cssrs-for-communities-and-healthcare/.

Horowitz, L. M., Bridge, J. A., Teach, S. J., et al. (2012). Ask Suicide-Screening Questions (ASQ): A brief instrument for the pediatric emergency department. Archives of Pediatrics and Adolescent Medicine, 166(12), 1170–1176. https://doi.org/10.1001/archpediatrics.2012.1276.

Horowitz, L. M., Snyder, D. J., Boudreaux, E. D., et al. (2020). Validation of the Ask Suicide-Screening Questions for adult medical inpatients: A brief tool for all ages. Psychosomatics, 61(6), 713–722. https://doi.org/10.1016/j.psym.2020.04.008.

Joint Commission. (2026, updated April 21). Ligature and/or suicide risk reduction: Screening requirements, NPSG.15.01.01. https://www.jointcommission.org/en-us/knowledge-library/support-center/standards-interpretation/standards-faqs/000001215.

National Institute for Health and Care Excellence. (2022). Self-harm: Assessment, management and preventing recurrence (NG225). https://www.nice.org.uk/guidance/ng225.

National Institute of Mental Health. Ask Suicide-Screening Questions (ASQ) Toolkit, information sheet, clinical pathways, and brief suicide safety assessment guides. https://www.nimh.nih.gov/research/research-conducted-at-nimh/asq-toolkit-materials.

Posner, K., Brown, G. K., Stanley, B., et al. (2011). The Columbia-Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. American Journal of Psychiatry, 168(12), 1266–1277. https://doi.org/10.1176/appi.ajp.2011.10111704.

United States Preventive Services Task Force. (2022). Depression and suicide risk in children and adolescents: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-children-adolescents.

United States Preventive Services Task Force. (2023). Depression and suicide risk in adults: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults.

U.S. Department of Veterans Affairs and U.S. Department of Defense. (2024). VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/MH/srb/index.asp.